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Epidemic attenuationDengue is an expanding arboviral disease of variable severity characterized by the emergence of virus strains with
greater ﬁtness, epidemic potential and possibly virulence. To investigate the role of dengue virus (DENV) strain
variation on epidemic activity we studied DENV-2 viruses from a series of South Paciﬁc islands experiencing
outbreaks of varying intensity and clinical severity. Initially appearing in 1971 in Tahiti and Fiji, the virus was
responsible for subsequent epidemics inAmerican Samoa,NewCaledonia andNiue Island in1972, reaching Tonga in
1973 where there was near-silent transmission for over a year. Based on whole-genome sequencing and
phylogenetic analysis on 20 virus isolates, Tonga viruses were genetically unique, clustering in a single clade.
Substitutions in the pre-membrane (prM) and nonstructural genes NS2A and NS4A correlatedwith the attenuation
of the Tongan viruses and suggest that genetic change may play a signiﬁcant role in dengue epidemic severity..J. Gubler),
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Dengue is an arboviral infectious disease transmitted by anthro-
pophilic Aedes mosquitoes, primarily Ae. aegypti, which typically
breed in water-holding containers within human habitations
(Rodhain and Rosen, 1997). The dengue virus (DENV), a 11 kb
positive-sense, single-strand RNA virus of the family Flaviviridae, has
four closely related but antigenically distinct serotypes (DENV-1 to
-4), none of which provide long-lasting cross-protective immunity to
the other serotypes. Infection with any one of the four serotypes can
be asymptomatic or produce a spectrum of clinical symptoms from
non-speciﬁc febrile illness, dengue fever (DF), to the more severe
dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS).
While dengue disease incidence has risen at an alarming rate over the
last few decades to where it now accounts for 50–100 million
infections annually worldwide (WHO, 1997), the mechanism(s) by
which DENV causes disease remain(s) unclear and no antiviral
therapy or vaccine is yet available. Nonetheless, various risk factors
for DHF/DSS have been identiﬁed, including viral strain, vectorcompetency, age and genetic background of the host, and secondary
infection by a heterologous DENV serotype (Gubler, 1988, 1998;
Halstead, 2007). The major question in DENV research is under-
standing how these factors conspire to cause such large variation in
disease and epidemic intensity. Here we take advantage of a natural
experiment in which many, if not most, of the confounding factors in
dengue disease dynamics could be excluded except for virus
evolution, thus allowing for a clearer examination of the effects of
strain variation and genetic change on dengue virus epidemic
severity. We conducted whole-genome sequencing and phylogenet-
ic analysis of DENV-2 collected during a series of outbreaks amongst
similarly naive host populations in order to determine whether an
apparent attenuation in the ultimate transmission event correlated
with genetic change in the virus. Thus, this study offers an
opportunity to isolate the effects of virus genetic variation from
seropositivity rates on epidemic behavior.Epidemiology
Our study derives from epidemiological, clinical and virologic
observations on a series of outbreaks of dengue type-2 virus (DENV-
2) in the South Paciﬁc from 1971 to 1974, which were notable for
abruptly shifting from a distinctly virulent character to one that was
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major regional pandemic of DENV-1 that affected most islands from
1942 to 1945, dengue was absent from the Paciﬁc for almost 30 years
(Gubler, 1997) aside from small outbreaks of DENV-3 in Tahiti in
1964 and 1969 (Laigret et al., 1967, Saugrain et al., 1970). However,
in early 1971 DENV-2 appeared almost simultaneously among
populations that were largely immunologically naive on Fiji and
Tahiti (Moreau et al., 1973; Maguire et al., 1974; Rosen, 1977), then
spread to New Caledonia, Niue and Samoa in 1972 (Loison et al.,
1973; Barnes and Rosen, 1974; Rosen, 1977), followed by Tonga in
late 1973 (Gubler et al., 1978). The outbreaks in Tahiti, New
Caledonia, and Niue were all explosive and spread rapidly, infecting
from 40% to 50% on New Caledonia and Tahiti and up to 90% on Niue.
These outbreaks were of severe classical dengue fever and associated
with high virus isolation rates (N 75%) (Gubler, 1997). Hemorrhagic
disease was observed as more common and severe particularly in
Tahiti (Moreau et al., 1973) and Niue, where there were 12 deaths,
and the illness was recorded as being of a more distinctly
hemorrhagic form as opposed to manifesting as dengue shock
syndrome caused by vascular leakage (Barnes and Rosen, 1974;
Rosen, 1977; South Paciﬁc Dengue Commission, 1974). Other islands,
such as American Samoa for which little epidemiological data is
available, also experienced outbreaks during this time although of a
character described subsequently as “smoldering” (Gubler, 1997).
From 1971 through most of 1973, the Kingdom of Tonga remained
unaffected by these epidemics on neighboring islands but given the
progression of the epidemics, public health ofﬁcials in Tonga anticipated
an epidemic of corresponding severity on their island. In addition, high
rainfall over the fall and winter of 1973 had led to greater than usual
populations of Ae. aegypti as well as Ae. tabu, thus heightening concern
(Gubler et al., 1978). Surprisingly, nomajor outbreak occurred. In January,
1974, one of us (DJG) requested that paired serum samples be collected
from persons with viral syndrome in Tonga. Of eight patients tested, four
were positive for dengue. Subsequently, serologic testing of serum
samples collected in August 1973 for a ﬁlariasis survey, however,
documented that DENV-2 had been introduced to Tonga sometime
prior to August 1973 (Gubler et al., 1978). Again anticipating a large
epidemic, investigationwas initiated to study themagnitudeandduration
of viremia and the competence of the mosquito vector. However, only
cases of mild illness, mostly viral syndrome, were observed. The number
of people seekingmedical attention at thehospital peakedat 165 inMarch
and 127 in April of 1974 (South Paciﬁc Dengue Commission, 1974). Case
numbers fell sharply thereafter, with dengue ceasing to be recognized by
the end of October of the same year. Among those individuals who were
either hospitalized or seen as outpatients, almost all had remarkablymild
clinical manifestations of short duration. Incidence of hemorrhage was
extremely low, rates of virus isolationwere very low (∼33%) and viremia
inmost patientswas too low to infectmosquitoes (only oneof six patients
on whommosquitoes were fed) (Gubler et al., 1978).
Nonetheless, it was clear that mosquito and human populations on
Tongawere capable of sustaining a severe DENV outbreak: in contrast to
this 1974DENV-2outbreak inTonga, a subsequentoutbreakon the same
islands in 1975 but this time involving DENV-1 was particularly severe.
The latter virus' progression through the population of Tonga was
explosive, the incidence of hemorrhage higher, and there was a fatality
rate of 12 persons (compared to none previously) (Gubler et al., 1978).
Among the few (11) serum samples collected from this outbreak, DENV-
1was isolated from4out of 6 patientswith primary infections, including
one 26-year-old female fatality with DHF. DENV-1was also isolated in 1
out of the 4 patients with secondary infections. Thus, primary and
secondary infections were roughly equal (Gubler et al., 1978).
In summary, all islands affected by dengue outbreaks from 1971 to
1974 and for which serological testing and/or isolates were collected
had outbreaks of the American genotype of DENV-2. With the
exception of American Samoa, islands from which DENV-2 was
isolated previous to Tonga experienced sudden outbreaks that showeda rapid increase in the number of people affected and which were
characterized by hemorrhagic disease of unusual severity and high
viremia levels. In Tonga, however, the 1974 outbreak of the same
serotype and genotypewas remarkablymild, with the virus seemingly
attenuated, and exhibiting near-silent transmission.
Results
Sequence analysis
Themaximum likelihood (ML) generated phylogenetic tree consist-
ing of the 20 South Paciﬁc isolates plus the additional 54 publicly
available DENV-2 sequences (Fig. 1) unequivocally conﬁrmed (a) that
the viruses isolated during the South Paciﬁc epidemic sweepwere of the
same evolutionary lineage, (b) that these same isolates all belonged to
the DENV-2 American genotype, which includes new world isolates
dating back to the 1950s, and (c) that all stemmed from a single
introduction into the region from the Americas. PAUP*, MrBayes, and
RAxML generated trees resulted in the same consensus topology.
Posterior node probabilities and bootstrap support values indicated
100% support for critical nodes on the tree, conﬁrming both the
robustness of the tree and theplacement of the South Paciﬁc isolates in a
single clade within the American DENV-2 genotype.
The maximum clade credibility phylogenetic tree exclusively of the
20 South Paciﬁc isolates rooted with other American genotype
sequences (Fig. 2) revealed the Tonga sequences clustering into a
distinctly monophyletic clade (posterior node probability of 1; strong
bootstrap value of 97%, Supplementary Fig. 1A), lending support to the
hypothesis that there is a genetic correlation to the observed clinical and
epidemiologic attenuation. The Tonga clade also associated with the
divergent and artiﬁcially evolved vaccine strain derived from Tonga
(recombinant vaccine strain reported in Blaney et al., 2004, passaged 3
times after assembly and point mutations). Interestingly, 3 out of the 4
isolates from American Samoa, characterized by a “smoldering” and
somewhat less intense epidemic during this period, group together but
were distinct from the Tongan lineage (Fig. 2).
Amino acid substitutions associated with the Tonga clade
Mapping of the distribution of amino acid changes onto the Tonga
clade allowed us to identify 3 distinct substitutions speciﬁcally
associated with the Tongan samples; in NS4A which saw a change
from an isoleucine to a methionine at gene amino acid residue 46
(I464AM) that deﬁnes all Tongan isolates including the artiﬁcially
derived vaccine strain, in the pre-membrane (prM) gene region which
had a histidine to arginine substitution at residue 54 (H54pMR) and
deﬁnes all naturally isolated Tongan samples, and in NS2A which
experienced a serine to glycine substitution at residue 83 (S832AG) and
deﬁnes a subset of Tongan isolates (Fig. 2).
Analysis of rates of nonsynonymous (dN) to synonymous (dS)
substitution identiﬁed no signiﬁcant positive selection pressure on
amino acid substitutions throughout the South Paciﬁc outbreaks or
speciﬁcally on the Tongan clade. Tests for recombination tentatively
identiﬁed an incongruous Tahiti isolatewhichwas removed fromthe list
of compared sequences to await further analysis.
Viral demographics
Coalescent-based reconstruction of the demographic history of the
American genotype DENV-2 in the South Paciﬁc based on estimates of
relative genetic diversity (Net) over time suggests that viral effective
population sizes (Ne) experienced a decline representing a genetic
bottleneck when introduced from the Caribbean. This was followed by
an increase in diversity suggestive of exponential growth during ﬁrst
establishment in the South Paciﬁc in 1971, followed by a brief decline
starting around 1972 that did not reach former population lows and
Fig. 1.MLtreeof isolates fromSouthPaciﬁc sweepplacedwithin other representativeDENV-2genotypes, includingwholegenome(Zhanget al., 2006) andEgene sequences (Twiddyetal.,
2002a,b). E gene sequences from sylvatic DENV-2 strains used as outgroups to root tree. Node numbers are bootstrap support values from 100 ML replicates run in the RAxML program.
Sequences generated in this study are available on NCBI's GenBank (HM582099-HM582117). A full list of accession numbers of all sequences used is available upon request.
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Fig. 2.Maximum clade credibility tree of isolates from the South Paciﬁc sweep on a temporal scale, aligned with the effective virus population size estimates (Bayesian Skyline plot)
based on genetic diversity, both generated in BEAST (Drummond and Rambaut, 2007). Tree labels indicate serotype/ISO 2-letter country-code/strain ID/year of collection. E gene
sequences from American genotype strain of serotype 2, D2/PR/PR152/1969 (GenBank accession number AF264054) used as outgroup to root the tree. Node numbers are posterior
node probabilities. Bold values are inferred amino acid substitutions thatmay correlate with strain attenuation. Corresponding Bayesian skyline plot showsmean effective number of
infections (Ne) over the same time scale (solid black line, left-hand axis) with shaded area representing 95% high probability densities.
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late 1973 (Fig. 2). This is consistent with epidemiologic data of large
initial case numbers in 1971 followed by a waning: approximately
40,000 cases in Tahiti in 1971 (in the absence of consistent reporting, “it
was estimated that at least half the population [of 80,000]was affected,”
Moreau et al., 1973); 3400 acute cases and at least 20,000 subclinical
cases in Fiji in 1971 (Maguire et al., 1974); approximately 25,000 cases
in the capitol of New Caledonia, 1971–1972 (extrapolated by the
authors from a 40% affected rate of a population of 60,000, Loison et al.,
1973); 790 diagnosed cases, but probably closer to 2070 symptomatic
infections (45% affected rate of 4,600 people) in Nuie Island in 1972
(Barnes and Rosen, 1974); 30 cases in American Samoa in 1972 (Gubler,
D., Kuberski, T., and Rosen, L., unpublished data); and 24 conﬁrmed
cases, and fewer than 100 people reporting symptomatic illness in
Tonga in 1974, population 95,000 (Gubler et al., 1978).
Discussion
In this paper we address the relative importance of DENV strain
variation to epidemic potential or virulence by focusing on a simpliﬁed
transmission arena. Support for the differential virulence of strains
began with experimental infections of human volunteers (Sabin, 1952)
and the use of attenuated strains as a basis for vaccine research (Blaney
et al., 2004). This has been observed as well in numerous epidemiolog-
ical studies reporting attenuation in Tonga (Gubler et al., 1978) and
Indonesia (Gubler et al., 1981) as well as increased virulence and/or
epidemic severity in Sri Lanka (Messer et al., 2002), Venezuela
(Uzcategui et al., 2003), Peru (Watts et al., 1999) and the Western
Hemisphere, with the displacement of the American genotype of DENV-
2 by the more virulent Southeast Asian genotype (Rico-Hesse, 1990;
Cologna et al., 2005).
The evidence acquired from previous epidemiological studies
suggests that discovering associations between genetic and epidemio-
logical change may provide us with the best opportunity for inferring
factors of epidemic potential and/or virulence. The South Paciﬁcoutbreaks analyzed here provide unique advantages allowing us to
differentiate the effects of viral genetic variation from seropositivity
rates and other factors:
• All islands were relatively isolated and, except for Tahiti, had not seen
DENV for 25–30 years.
• The primary vector Ae. aegyptiwas equally abundant on all islands.
• Host genetic makeup was relatively similar as island populations were
either primarily Polynesian (Tahiti, Niue, American Samoa, Tonga) or
Melanesian (New Caledonia, Fiji).
• Well-documented epidemiologic, serological and clinical data are
available for all isolates used in this study.
The transmission rate can affect epidemic severity and thus the role of
mosquitoes in thedifferentialDENV-2 transmissionbetween islandsbears
examination. No information is available from the 1971 outbreak on
Tahiti, but on Fiji Ae. aegyptiwas found in all areas of conﬁrmed infection
with the exception of the neighboring island of Rotuma. There, only the
endemic species Ae. rotumae was detected (Maguire et al., 1974; South
Paciﬁc Comm. 1974). In New Caledonia Ae. aegypti mosquitoes were
found to be abundant in all areas where dengue was occurring (Loison et
al., 1973) while in Niue, although Ae. aegypti had not been reported
previously, it was found subsequently and was assumed to be present
during the outbreak (Barnes andRosen, 1974; SouthPaciﬁc Comm.1974).
A number of Aedes species, including Ae. aegypti, and Ae. tabu, were
known to be present on Tonga during both the 1974 and 1975 outbreaks
although overall numbers were lower in 1975 and while each species'
relative numbers varied between Tongan island groups, these differences
didnot correspond to epidemic intensity (Gubler et al., 1978). Attempts to
infect both Ae. aegypti and Ae. tabu by feeding them on dengue patients
were successful in only one case and subsequent examination of salivary
glands found no DENV-2. Interestingly, infectivity evaluations using the
Tonga strain as a basis for vaccine development (Blaney et al., 2004) also
found that the strain failed to infect the midgut or head of Ae. aegypti, in
contrast to the highly infectious DENV-2 New Guinea prototype strain.
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differences in epidemic behavior seen on the different islands involved in
the 1971–1974 DENV-2 outbreaks. The primary vector, Ae. aegypti, was
found virtually on all islands in which dengue outbreaks occurred and is
the most anthropophilic. While vector competency has been shown to
vary between species aswell as betweendifferent geographic populations
of the same species (Rodhain and Rosen, 1997), no correlation has been
established between variations in competency on different South Paciﬁc
islands and their respective dengue epidemiology.
Evidence for some contribution of host factors to the epidemiological
pattern seen in the South Paciﬁc sweep is equally uncompelling. There
were numerous cases of patients with pre-existing conditions that might
have increased their susceptibility to hemorrhagic symptoms, yet no
overall pattern between islands that would explain the attenuation of
symptoms as seen in Tonga can be found. Likewise, while there is some
evidence for inter-ethnic differences in dengue disease prevalence or
severity, e.g., individuals of Africandescent appear to be less susceptible to
DENV infection (Sierra et al., 2007a,b), host genetics in terms of ethnicity
of the South Paciﬁc islands involved do not appear to correspondwith the
pattern of DENV-2 outbreaks described. As noted above, the affected
island populations were either primarily Polynesian (Tahiti, Niue,
American Samoa, Tonga) or Melanesian (New Caledonia, Fiji). The most
affected island, in terms of severity of symptoms andproportion of people
infected,Niue, and the least affected, Tonga, are bothmadeupprimarily of
Polynesians. Similarly, ethnicity did not inﬂuence the dramatically
different epidemic outcomes on Tonga itself between the attenuated
DENV-2 outbreak of 1974 and the 1975 DENV-1 outbreak with high
associated morbidity.
There is no evidence therefore that variation in vector populations or
host immunitywere signiﬁcant contributing factors to the differences in
epidemic severity seenbetween islands (Gubler et al., 1978). Rather, our
results strongly suggest a viral basis for such differences. Observers of
the original South Paciﬁc dengue outbreaks assumed that the outbreaks
on each island were caused by strains that were genetically and
evolutionarily related to each other. Given the geographic isolation of
these islands from the rest of the world, even greater then than today,
such a belief was warranted. Nevertheless, there was always the
possibility that the dramatic differences in epidemic behavior seen
betweenTonga and theother islandswas simply due to the introduction
of a different DENV-2 strain into Tonga. Phylogenetic analysis across all
DENV-2 genotypes (Fig. 1) clearly shows that the viruses responsible for
the South Paciﬁc outbreaks were all genetically related and the result of
a single introduction. The ML tree of isolates from the South Paciﬁc,
rooted with an American genotype outgroup (Fig. 2), provide further
evidence that the Tonga DENV-2 strains are conclusively derived from
the earlier Tahiti strains and not the result of a new introduction to the
region, as shown by the formation of the monophyletic Tongan clade
and the well-supported clustering of the Tonga clade with Tahiti, Fiji,
and New Caledonia as closest relatives. The inclusion of the Tongan-
derived, recombinant vaccine strain (Blaney et al., 2004) with the
Tongan clade also demonstrates a shared genetic signature correlated
with dramatic attenuation. Thus the DENV-2 phenotype of diminished
disease incidence appears to be characteristic of all members of the
clade and our phylogenetic analysis implicates speciﬁc synapomorphies
(shared derived genetic substitutions) as the cause.
The causal molecular basis for how the above synapomorphies affect
DENV attenuation is still unclear, however. If we consider the Tonga clade
as including the vaccine strain, the primary amino acid synapomorphy
associated with attenuation was I464AM, a nonconservative amino acid
substitution resulting in the presence of a sulfur group with potentially
large phenotypic effects. If we exclude the vaccine strain, as it had
presumably been artiﬁcially selected, then the synapomorphies deﬁning
the Tongan clade expand to also include H54prMR, a somewhat more
conservative substitution for a larger, more positive amino acid that may
nonetheless have phenotypic repercussions. A subset of Tongan isolates
was further distinguished by S832AG, also a nonconservative substitution,involving the loss of a potential phosphorylation/glycosylation residue for
a metal-binding residue. Although potentially of large phenotypic effect,
this last substitution was not shared by all Tongan isolates and therefore
probably not the attenuating change.
Although our selection analysis suggests that none of these amino
acid substitutionshadacceleratedﬁxation relative to silent substitutions,
as onewould see under strongpositive selection, nonetheless these tests
lack power under the small sample sizes (in terms of substitutions)
observed here and do not discount that the substitutions are
phenotypically signiﬁcant. While a number of studies have attempted
to identify speciﬁc structural differences that correlatewith clinical and/
or epidemic outcome (Chen et al., 2008; Cologna and Rico-Hesse, 2003;
Cologna et al., 2005; Leitmeyer et al., 1999) there is insufﬁcient evidence
to identify consistent speciﬁc genetic factors associatedwith theseDENV
phenotypes. In our case, correlation of speciﬁc amino acid substitutions
with epidemic attenuation implicates DENV genes (NS2A, NS4A and the
prM) whose function is poorly understood.
NS2A and NS4A have both been implicated in the inhibition of the
interferon-mediated antiviral immune response (Munoz-Jordan et al.,
2003) albeit to a lesser extent than NS4B. Interestingly, Umareddy et al.
(2008) found that such inhibitory effects were strongly strain
dependent (thoughnot serotype-speciﬁc), again suggesting amolecular
basis for strain variations in epidemic potential. NS2A genes may also
play a role, alongwith NS4B, in anchoring the viral replicase complex to
cellular lipid membranes (Chambers et al., 1989). NS2A has also been
found to be evolutionarily signiﬁcant, with adaptive substitutions
affecting epidemic patterns, in Puerto Rico amongst DENV-4 strains
(Bennett et al., 2003).
prM, aprecursor to theMprotein, is thought topromote infectivity of
mature virions upon rearrangement of virion surface structure after
proteolytic cleavage (Chang, 1997). Leitmeyer et al. (1999) identiﬁed
two amino acids in the prM that distinguished the more virulent
Southeast Asian genotype of DENV-2 from the American and noted
previous experiments (Bray and Lai, 1991) that demonstrated the
induction of protective antibody inmousemodels upon exposure to the
prM protein in combination with the membrane (M) protein.
Clearly, more work is required to determine whether the observed
attenuation is due to the amino acid substitutions identiﬁed or other
nucleotide substitutions that are either synonymous or occurred in the
5’ and 3’ non-translated regions. Regardless, the genetic substitutions
deﬁning the Tongan clade are consistent with a reduction in viremia
and/or viral resistance to host interferon.
Our analysis of viral demographics during this period of epidemic
expansion to near-silent transmission using the coalescent-based
skylineplot (Fig. 2) offers an interestingperspectiveon suchalternatives.
Following a decline in diversity and virus effective population sizes after
1972, there appears to be a period of stasis in viral population sizes (in
terms of numbers of infections) or possibly slow growth as DENV-2
arrived in Tonga. While this appears to contradict contemporary
observations that the Tonga attenuation was notable for both fewer
clinical infections and lowered case viremia, the 40% rate of secondary
infection in the 1975 DENV-1 Tonga epidemic supports that DENV-2
infections in 1974 were more numerous than reports based on clinical
data. Recall also that DENV-2 was ﬁrst introduced into Tonga prior to
August, 1973, based on antibody data, and that although symptomatic
and conﬁrmed cases were only noted beginning in 1974, silent
transmission had already occurred by this time (Gubler et al., 1978).
Dengue evolution has been characterized by vigorous purifying
selection (Holmes, 2003; Twiddy et al., 2002a,b), occasional positive
selection on certain amino acid sites (Bennett et al., 2003, 2006; Twiddy
et al., 2002a,b) and considerable genetic drift (Jarman et al., 2008),
particularly important in small populations. Genetic drift might be
expected to predominate as a force of evolutionary change in the South
Paciﬁc simply because islands experience relatively more population
bottlenecks, that is, drastic reductions of individuals leading to random
ﬁxation. Along with the bottleneck at each blood meal, which captures
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substantial seasonal variation in rainfall and/or temperature. Mosquito
populations on such islands that are dependent upon seasonal rainfall
can ﬂuctuate dramatically during the year (Iyengar, 1960). On the
southerly Paciﬁc islands, seasonal temperature changes can affect vector
gonotrophic cycle and/or the extrinsic incubation period. Nor are these
seasonal bottlenecks alleviated by vector immigration from off-island
since the islands are relatively isolated. In addition, susceptible host
populations experience rapid ﬂuctuations on islands where human
populations are limited, clustered so as to be more vulnerable to high
rates of transmission, and less often infused with new susceptibles due
to isolation bygeographic distance. Finally, viral lineage diversity should
decrease in proportion to smaller population sizes and the degree of
diminished frequency of importation imposed by the geographic
isolation inherent in islands. By all accounts, this isolation was even
more pronounced at the time of the outbreak when between-island
transportation was much more limited than today.
This examination of the evolutionary drivers of epidemic intensity
takes advantage of the uniqueness of the South Paciﬁc islands in the
early 1970s. In contrast to those endemic/hyperendemic regions
where the majority of dengue studies have taken place, such as
Southeast Asia, the Caribbean, or South America, dengue viruses are
not hyperendemic and serotypes rarely appear to co-circulate among
island populations for any length of time. It may also be worth
considering that the variety of vector species unique to the South
Paciﬁc may contribute to a high level of endemism, and furthermore
that the mosquito species interacting with humans in the relatively
non-urbanized communities of the South Paciﬁc are potentially
greater than in hyperendemic areas of dengue transmission, which
are often dominated by Ae. aegypti. Numerous species of the subgenus
Stegomyia, scutellaris group, are indigenous to various islands in the
South Paciﬁc (e.g., Ae. polynesiensis, Ae. hebrideus, Ae. cooki, Ae.
rotumae, Ae. kesseli, Ae. tongae tabu, and Ae. tongae tongae) and include
unique adaptations such as desiccation-resistant eggs (Huang and
Hitchcock, 1980; Rodhain and Rosen, 1997). Given these factors, as
well as the paucity of current research on dengue in the South Paciﬁc,
and the increasing impact of the disease on island populations, greater
research in this region is warranted and provides opportunities to
dissect DENV evolutionary dynamics in a non-hyperendemic arena.Materials and methods
Viruses
The20 isolates sequenced in this studywere collected and annotated
by Dr. Duane J. Gubler during the South Paciﬁc outbreaks (see Table 1.)
Note that none of the isolates came from patients exhibiting DHF as
deﬁned by WHO guidelines (WHO, 1997).Isolation of viral RNA, RT, PCR, and sequencing
Low passage isolates were used to infect C6/36 cells from which
viral RNA was extracted using the QIAamp viral RNA mini kit
(Qiagen). Reverse-transcription was performed using SuperScript III
Reverse Transcriptase (Invitrogen), and ampliﬁed by PCR using
PfuUltra II Fusion HS DNA polymerase (Stratagene), using primers
designed for 2× coverage of the entire ORF (RT-PCR conditions and
primer sequences can be obtained from the corresponding author).
Amplicons were separated by electrophoresis on 1% agarose gels and
puriﬁed using QIAquick Gel Extraction kits (Qiagen). Both strands of
the resulting puriﬁed DNA fragments were sequenced at the UH
Manoa Advanced Studies in Genomics, Proteomics and Bioinformatics
sequencing facility using an Applied Biosystems 3730XL DNA
Analyzer.Sequence analysis
Sequencher 4.7 (Gene Code Corp.) was used to edit and align
completed genomes and alignments veriﬁed in Se-Al 2.0 (Rambaut,
2002). To provide genotypic, geographic and temporal context, 54
publicly available sequences spanningall knownDENV-2genotypes and
representing a comprehensive and diverse assemblage of dengue
viruses across the serotype were aligned with the South Paciﬁc isolates
as above. Alignments were imported into PAUP* 4.0b10 (Swofford and
Sullivan, 2003) and RAxML (Stamatakis et al., 2008) for phylogenetic
analysis. Sequences generated in this study have been assigned
GenBank accession nos. HM582099-HM582117. A full list of accession
numbers of all sequences used is available upon request.
Evolutionary relationships among the South Paciﬁc DENV-2 isolates
were inferred using maximum likelihood (ML) to generate two
phylogenetic trees. The ﬁrst ML tree provided a genotypic context for
the 20 South Paciﬁc isolates and examines whether in situ evolution
rather than multiple source introduction has occurred by including the
54 publicly available sequences (mentioned above), rooted with four
sylvatic serotype-2 strains (Genbank accession numbers AF231719,
AF231718, AF231717, AF231720). The second tree consisting only of
South Paciﬁc isolates rooted with an older American genotype from
Puerto Rico, 1969 (Genbank accession number AF264054) as an
outgroup examines whether Tonga isolates form a unique and distinct
clade apart from the other South Paciﬁc sequences.
Trees were estimated using the best ﬁtting model of nucleotide
substitution identiﬁed by Modeltest 3.7 (Posada and Crandall, 1998);
the Tamura-Nei plus Gamma plus I model that includes the following
substitution rate parameters (A-C= 1.0, A-G=13.913, A-T= 1.0, C-
G= 1.0, C-T= 39.9977, G-T= 1.0), with a gamma distribution of
among-site rate variation (4 categories) with a shape parameter (∝)
of 0.9517 and 69.2% invariable sites (substitution model TrN+I+G).
Phylogenies in PAUP* were generated under successive rounds
of subtree pruning-regrafting (SPR) branch swapping, updating
parameter estimates at each round.
ML tree topologies and node support were veriﬁed by generating
Bayesian posterior probability values for each node using MrBayes
(Huelsenbeck and Ronquist, 2001; Ronquist and Huelsenbeck, 2003)
based on 10,000,000 generations, ESS (effective sample size) of at least
100, and burnin of 12000. The average standard deviation of split
frequencies between 4 MCMC chains was 0.012386 (South Paciﬁc
isolates plus 54 added DENV-2 sequences) and 0. 021130 (South Paciﬁc
isolates plus American outgroup). In addition, 100 ML bootstrap
replicates were implemented in the RAxML BlackBox web server
(Stamatakis et al., 2008) as an additional measure of node support. A
GTR plus G plus I model of evolution similar to that above was used in
both cases, since MrBayes and RAxML BlackBox cannot accommodate
the TrN93 model. Node support values and topologies generated from
all threemethods–PAUP*,MrBayes andRAxMLBlackBox–were virtually
identical. Fig. 1 shows the results fromRAxMLBlackBoxand Fig. 2 shows
the South Paciﬁc lineage Maximum Clade Credibility tree (RAxML tree,
PAUP*MLandMrBayes consensus trees for the SouthPaciﬁc ingroupare
available as Supplementary Figures 1A, B, and C, respectively).
Tests for recombination among the South Paciﬁc DENV-2 isolates
were carried out using the GARD detection method with the TrN93
nucleotide substitution bias model (chosen by the HyPhy automatic
model selection tool), Beta-Gamma rate variation and 3 rate classes
(DataMonkey.org). In the event that breakpoints were found, alterna-
tive phylogenies were explored by generating neighbor joining trees
with bootstrap resampling (100 replications) in PAUP* for the multiple
alignments of South Paciﬁc sequences on either side of the breakpoint
and under the same model of evolution.
As a means of identifying whether the Tonga attenuated phenotype
correlatedwith speciﬁc genetic changes,we used a parsimony approach
implemented inMacClade 4.08 (Maddison andMaddison, 2003) tomap
the most parsimonious distribution of amino acid changes onto the
Table 1
Epidemiologic and clinical data for isolates used in this study.
Strain ID Passa Onset date Isolation: date/time Diseaseb Age Race Sex Travel
history
Notes/location
D2/AS/UH73/1972 2c 6/22/1972 1972 Febrile acute 33 P M American Samoa
D2/AS/UH77/1972 2c 6/21/1972 1972 Febrile acute 50 P M Never out of
Am. Samoa
American Samoa
D2/AS/UH79/1972 2c 6/21/1972 1972 Afebrile acute 50 P M Never out of
Am. Samoa
American Samoa
repeat of S5277
D2/AS/UH85/1972 2c 6/21/1972 1972 Febrile acute 26 P F Never out of
Am. Samoa
American Samoa
D2/FJ/UH21/1971 4 n.d. 1971 DF n.d. n.d. n.d. n.d. Fiji
D2/FJ/UH40/1971 2 n.d. 1971 DF n.d. n.d. n.d. n.d. Fiji
D2/FJ/UH22/1971 3 n.d. 1971 DF n.d. n.d. n.d. n.d. Fiji
D2/NC/UH37/1971 2c 12/31/1971 12/31/1971 n.d. 60 C? M n.d. New Caledonia
D2/NC/UH97/1972 2c 1/26/1972 1/27/1972 8:15 A.M. Headache, joint pain 49 C F Born in France,
in NC 1.5 yrs
New Caledonia
D2/PF/UH50/1972 3 n.d. 1972 DF 7 n.d. F n.d. French Polynesia
D2/PF/UH57/1971 2c n.d. 1971 DF n.d. n.d. n.d. n.d. French Polynesia
D2/PF/UH00/1973 2c 4/12/1973 4/15/1973 DF n.d. n.d. F n.d. French Polynesia
D2/PF/UH48/1971 2c n.d. 1971 DF n.d. n.d. n.d. n.d. French Polynesia
D2/TO/UH16/1974 2c 4/16/1974 4/16/1974 P.M. Febrile, myalgia, arthralgia,
no rash nor hemorrhage
16 P F Never out of Tonga Tonga
D2/TO/UH19/1974 2c 4/16/1974 4/16/1974 7:30 P.M. Febrile 16 P F Never out of Tonga Tonga, repeat of
S14616
D2/TO/UH20/1974 2c 4/16/1974 4/17/1974 8:30 A.M. Febrile, myalgia, no rash nor
hemorrhage
19 P F Never out of Tonga Tonga
D2/TO/UH39/1974 2c 4/17/1974 4/18/1974 2:30 P.M. Fever, headache 16 P F Never out of Tonga Tonga
D2/TO/UH44/1974 2c 4/16/1974 4/19/1974 11:30 A.M. Afebrile, headache no rash nor
hemorrhage
16 P F Never out of Tonga Tonga, repeat of
S14616; 5th blood
D2/TO/UH94/1974 2c 4/25/1974 4/26/1974 10:15 A.M. Febrile, hematemesis, melena,
no other evidence of
hemorrhage
15 P F Never out of Tonga Tonga
D2/TO/UH04/1974 2c 4/19/1974 4/26/1974 4 P.M. Febrile, headache, myalgia 31 P M Never out of Tonga Tonga
Additional clinical details are marked – DF indicates that no further clinical data is available. No patients exhibited dengue hemorrhagic fever (DHF) as deﬁned by WHO criteria
(WHO, 1997).
a Viral passage history.
b All patients were classiﬁed as having classical dengue fever (DF).
c First passage in adult mosquito.
511A. Steel et al. / Virology 405 (2010) 505–512branches of the ML phylogenetic tree made up of the 20 South Paciﬁc
isolates, noting amino acid changes that occurred on branches both
antecedent and within the Tonga clade.
To determine whether substitutions amongst the South Paciﬁc
isolates had been ﬁxed by positive selection rather than random
genetic drift, we estimated the relative rates of nonsynonymous (dN)
to synonymous (dS) nucleotide substitutions across coding portions
of a multiple alignment that included the South Paciﬁc isolates as well
as the four American genotype outgroup sequences. We utilized two
methods to assess the extent of adaptive evolution among the taxa in
this alignment; PARRIS (rates across the alignment) and GABranch
(rates on individual branches) (DataMonkey.org). Bothmethodswere
run under the TrN93 nucleotide substitution bias model.
Epidemiologic observations suggest dramatic changes in virus
population sizes throughout this period. Virus population sizes are
expected to have been mounting during the 1971–1972 series of
epidemics, but may have dropped dramatically in Tonga in 1974.
Effective population size for a virus like dengue is a function of the
census population size (estimated from conﬁrmed cases) divided by
the variance in successful subsequent transmissions, or in other
words, the effective number of infections, those that go on to produce
subsequent infections. We estimated virus effective population sizes
(Ne) over the timespan of our study as a function of relative virus
genetic diversity amongst sequences isolated at different points in
time. Most isolates in our study were dated to month and day of
sampling. Relative genetic diversity (Net, where t is the generation
time, set to 2 weeks for DENV) is an indicator of effective population
size under a neutral evolutionary process based on coalescent theory.
We used a Bayesian Markov Chain Monte Carlo (MCMC) inferenceframework in the program BEAST to independently estimate relative
genetic diversity and Ne while incorporating uncertainty in the
phylogeny by integrating across tree topologies (Drummond and
Rambaut, 2007).
Within BEAST we used the Bayesian Skyline model, employing a
relaxed uncorrelated lognormal molecular clock model and a codon
model of substitution (Goldman and Yang, 1994), chosen over a strict
clockmodel on the basis of a likelihood ratio test andAIC. Chain length for
MCMC sampling was 25 million generations, sampling every 1000
generations. Adequate convergence of the chains and effective sample
sizes were assessed in Tracer (1.4.1, Drummond and Rambaut, 2007).
Statistical uncertainty in mean Ne estimates is reﬂected in 95% Highest
Probability Densities (HPD). MCC topologies were generated in the
TreeAnnotator programandwere identical to topologies generated by the
other tree estimation methods.Acknowledgments
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